novavax nuvaxovid - Search News

News

Novavax Vaccine Gets FDA Approval

Stocktwits on MSN · 6h

Novavax Stock Rips Nearly 20% Pre-Market After FDA Approves Its COVID-19 Vaccine Nuvaxovid

Pharmaceutical giant Novavax on Monday announced that the U.S. Food and Drug Administration (FDA) approved its COVID-19 vaccine, Nuvaxovid. Novavax’s shares traded nearly 20% in pre-market trading at the time of writing.

Investopedia on MSN · 5h

Novavax Stock Soars on FDA Approval for New COVID-19 Vaccine

Key Takeaways Novavax received Food and Drug Administration approval for its new, protein-based COVID-19 vaccine.The shot, Nuvaxovid, is designed for older adults and those between the ages of 12 and 64 who have underlying conditions that puts them at higher risk from the disease.

MarketWatch · 7h

Novavax Shares Rise on FDA License Application Approval for Nuvaxovid

The biotechnology company said the FDA approved the biologics license application for Nuvaxovid to prevent Covid-19 in adults ages 65 and up and individuals ages 12 through 64 who have at least one underlying condition that puts them at high risk for severe outcomes from the coronavirus.

Schaeffer's Investment Research4h

Novavax Stock Soars on FDA Approval for COVID Vaccine

In the options pits, NVAX has already seen quadruple the overall options volume it typically sees in an entire session, with ...

19hon MSN

FDA approves Novavax's Covid-19 vaccine with limitations

The U.S. Food and Drug Administration approved Novavax's Covid-19 vaccine with age restrictions after a six-week delay.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results